Shandong Xinhua Pharmaceutical Company Limited (FRA:XIN)
Germany flag Germany · Delayed Price · Currency is EUR
0.7300
-0.0100 (-1.35%)
Last updated: Jan 28, 2026, 8:07 AM CET

FRA:XIN Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Dec '21 Dec '20
Cash & Equivalents
1,2341,245918.331,159744.66855.77
Cash & Short-Term Investments
1,2341,245918.331,159744.66855.77
Cash Growth
6.57%35.57%-20.75%55.61%-12.98%23.94%
Accounts Receivable
1,2851,120949.16970.63870.46518.55
Other Receivables
10.239.59.3412.6517.4225.16
Receivables
1,2951,129958.5983.28887.87543.71
Inventory
1,2521,2731,3131,2121,0281,124
Prepaid Expenses
-0.033.41--7.15
Other Current Assets
116.879.78121.1102.9593.88155.88
Total Current Assets
3,8993,7273,3143,4572,7542,687
Property, Plant & Equipment
4,2044,2964,0614,0003,7663,539
Long-Term Investments
300.65306.42241.37239.18260.2316.62
Other Intangible Assets
561.66565.04494.94474.11466.45449.25
Long-Term Deferred Tax Assets
15.5424.9223.4815.6215.1723.52
Long-Term Deferred Charges
16.49.9914.468.6110.5411.92
Other Long-Term Assets
96.8290.75136.7769.8559.9965.93
Total Assets
9,0949,0208,2868,2657,3327,093
Accounts Payable
1,2951,1591,1781,0901,066742.9
Accrued Expenses
36.99137.28203.11159.43122.35144.87
Short-Term Debt
513.51580.16283.96118.02269.46200.42
Current Portion of Long-Term Debt
508.38312.26271.97714.77421.03356.55
Current Portion of Leases
-1.41.782.692.81.56
Current Income Taxes Payable
27.616.695.037.9912.24.42
Current Unearned Revenue
76.0396.84149.14593.26100.4377.79
Other Current Liabilities
525.11502.3393.16472.23507.26552.53
Total Current Liabilities
2,9822,7962,4863,1582,5022,381
Long-Term Debt
498.32771.54799.4545.66946.21,063
Long-Term Leases
1.031.111.582.726.7723.93
Long-Term Unearned Revenue
73.3683.25100.67118.37133.97146.5
Long-Term Deferred Tax Liabilities
120.21122.5399.2166.4465.6169.31
Other Long-Term Liabilities
28.0628.0623.5623.5626.4618.14
Total Liabilities
3,7033,8023,5103,9153,6813,702
Common Stock
689.78682.41674.68669.63627.37621.86
Additional Paid-In Capital
1,2061,1451,055998.14677.94644.91
Retained Earnings
3,0732,9892,7062,3452,0341,780
Comprehensive Income & Other
180.9175.86117.01113.68128.37177.21
Total Common Equity
5,1494,9924,5534,1263,4683,224
Minority Interest
241.37225.91222.65223.29183.2167.5
Shareholders' Equity
5,3905,2184,7764,3503,6513,391
Total Liabilities & Equity
9,0949,0208,2868,2657,3327,093
Total Debt
1,5211,6661,3591,3841,6461,645
Net Cash (Debt)
-286.81-421.45-440.36-225.11-901.58-789.42
Net Cash Per Share
-0.41-0.61-0.64-0.34-1.44-1.26
Filing Date Shares Outstanding
689.78689.78682.41669.63627.37627.37
Total Common Shares Outstanding
689.78682.41674.68669.63627.37621.86
Working Capital
916.43931.23828.33298.47252.08305.83
Book Value Per Share
7.467.316.756.165.535.18
Tangible Book Value
4,5874,4274,0583,6523,0012,775
Tangible Book Value Per Share
6.656.496.015.454.784.46
Buildings
-2,4112,2712,2442,0781,948
Machinery
-5,1284,7034,4684,0113,690
Construction In Progress
-781.1730.55545.89562.96416.99
Source: S&P Global Market Intelligence. Standard template. Financial Sources.